Report Detail
Global (United States, European Union and China) Cancer Therapeutics and Supportive Care Drugs Market Research Report 2019-2025
- RnM3665410 |
- 13 August, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
The cancer supportive care product market consists of drugs intended to prevent or treat the symptoms of cancer, and reduce the side effects of cancer treatments. Instead of extending a patient’s life expectancy, the emphasis is on improving overall quality of life. The key indications covered in this report are cancer pain, oral mucositis, chemotherapy-induced neutropenia (CIN), chemotherapy-induced anemia (CIA), chemotherapy-induced nausea and vomiting (CINV) and bone metastasis. These indications are not only distressing for patients, but can also lead to treatment cessation, which in turn increases patient mortality. As the number of people being diagnosed with cancer grows and access to effective treatment that allows patients to survive longer increases, demand for safe and effective cancer supportive care drugs will rise.
In 2019, the market size of Cancer Therapeutics and Supportive Care Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of 9.0% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer Therapeutics and Supportive Care Drugs.
This report studies the global market size of Cancer Therapeutics and Supportive Care Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cancer Therapeutics and Supportive Care Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott Laboratories
AstraZeneca plc
Astellas Pharma
Bristol-Myers Squibb
Johnson & Johnson
Eli Lilly
Novartis
Pfizer
Sanofi
Teva Pharmaceuticals
Takeda Pharmaceuticals
AbbVie
Market Segment by Product Type
Cancer Therapeutics
Supportive Care Drugs
Market Segment by Application
Hospital
Retail
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cancer Therapeutics and Supportive Care Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Therapeutics and Supportive Care Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cancer Therapeutics and Supportive Care Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cancer Therapeutics and Supportive Care Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Cancer Therapeutics
- 1.3.3 Supportive Care Drugs
- 1.4 Market Segment by Application
- 1.4.1 Global Cancer Therapeutics and Supportive Care Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Retail
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cancer Therapeutics and Supportive Care Drugs Market Size
- 2.1.1 Global Cancer Therapeutics and Supportive Care Drugs Revenue 2014-2025
- 2.1.2 Global Cancer Therapeutics and Supportive Care Drugs Sales 2014-2025
- 2.2 Cancer Therapeutics and Supportive Care Drugs Growth Rate by Regions
- 2.2.1 Global Cancer Therapeutics and Supportive Care Drugs Sales by Regions 2014-2019
- 2.2.2 Global Cancer Therapeutics and Supportive Care Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cancer Therapeutics and Supportive Care Drugs Sales by Manufacturers
- 3.1.1 Cancer Therapeutics and Supportive Care Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cancer Therapeutics and Supportive Care Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Therapeutics and Supportive Care Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cancer Therapeutics and Supportive Care Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Cancer Therapeutics and Supportive Care Drugs Price by Manufacturers
- 3.4 Key Manufacturers Cancer Therapeutics and Supportive Care Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cancer Therapeutics and Supportive Care Drugs Market
- 3.6 Key Manufacturers Cancer Therapeutics and Supportive Care Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Cancer Therapeutics Sales and Revenue (2014-2019)
- 4.1.2 Supportive Care Drugs Sales and Revenue (2014-2019)
- 4.2 Global Cancer Therapeutics and Supportive Care Drugs Sales Market Share by Type
- 4.3 Global Cancer Therapeutics and Supportive Care Drugs Revenue Market Share by Type
- 4.4 Cancer Therapeutics and Supportive Care Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cancer Therapeutics and Supportive Care Drugs Sales by Application
6 United States
- 6.1 United States Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Company
- 6.2 United States Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Type
- 6.3 United States Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Company
- 7.2 European Union Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Type
- 7.3 European Union Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Application
8 China
- 8.1 China Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Company
- 8.2 China Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Type
- 8.3 China Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Company
- 9.2 Rest of World Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Type
- 9.3 Rest of World Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Application
- 9.4 Rest of World Cancer Therapeutics and Supportive Care Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Cancer Therapeutics and Supportive Care Drugs Sales by Countries
- 9.4.2 Rest of World Cancer Therapeutics and Supportive Care Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Abbott Laboratories
- 10.1.1 Abbott Laboratories Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.1.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.1.5 Abbott Laboratories Recent Development
- 10.2 AstraZeneca plc
- 10.2.1 AstraZeneca plc Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.2.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.2.5 AstraZeneca plc Recent Development
- 10.3 Astellas Pharma
- 10.3.1 Astellas Pharma Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.3.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.3.5 Astellas Pharma Recent Development
- 10.4 Bristol-Myers Squibb
- 10.4.1 Bristol-Myers Squibb Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.4.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.4.5 Bristol-Myers Squibb Recent Development
- 10.5 Johnson & Johnson
- 10.5.1 Johnson & Johnson Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.5.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.5.5 Johnson & Johnson Recent Development
- 10.6 Eli Lilly
- 10.6.1 Eli Lilly Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.6.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.6.5 Eli Lilly Recent Development
- 10.7 Novartis
- 10.7.1 Novartis Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.7.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.7.5 Novartis Recent Development
- 10.8 Pfizer
- 10.8.1 Pfizer Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.8.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.8.5 Pfizer Recent Development
- 10.9 Sanofi
- 10.9.1 Sanofi Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.9.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.9.5 Sanofi Recent Development
- 10.10 Teva Pharmaceuticals
- 10.10.1 Teva Pharmaceuticals Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cancer Therapeutics and Supportive Care Drugs
- 10.10.4 Cancer Therapeutics and Supportive Care Drugs Product Introduction
- 10.10.5 Teva Pharmaceuticals Recent Development
- 10.11 Takeda Pharmaceuticals
- 10.12 AbbVie
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cancer Therapeutics and Supportive Care Drugs Sales Channels
- 11.2.2 Cancer Therapeutics and Supportive Care Drugs Distributors
- 11.3 Cancer Therapeutics and Supportive Care Drugs Customers
12 Market Forecast
- 12.1 Global Cancer Therapeutics and Supportive Care Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Cancer Therapeutics and Supportive Care Drugs Sales Forecast by Type
- 12.3 Global Cancer Therapeutics and Supportive Care Drugs Sales Forecast by Application
- 12.4 Cancer Therapeutics and Supportive Care Drugs Forecast by Regions
- 12.4.1 Global Cancer Therapeutics and Supportive Care Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cancer Therapeutics and Supportive Care Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on CancerTherapeuticsandSupportiveCareDrugs. Industry analysis & Market Report on CancerTherapeuticsandSupportiveCareDrugs is a syndicated market report, published as Global (United States, European Union and China) Cancer Therapeutics and Supportive Care Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of CancerTherapeuticsandSupportiveCareDrugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
